Bristol Myers Squibb Shows What AI-Enabled Manufacturing Actually Looks Like
Source: NYT > Business
While most U.S. manufacturers remain stuck in analog processes, Bristol Myers Squibb's cancer drug facility became the only American plant recognized by the World Economic Forum for AI innovation. The gap reflects capital allocation priorities and risk tolerance in regulated industries more than technology availability. Pharmaceutical and specialty manufacturers willing to integrate automation into high-stakes production are pulling ahead operationally and gaining WEF-level credibility that attracts talent, partners, and regulatory goodwill. Early movers in AI-enabled quality control and supply chain visibility are locking in efficiency advantages that slower adopters will struggle to match.